Barinthus Biotherapeutics Stock (NASDAQ: BRNS) stock price, news, charts, stock research, profile.
Open | $1.52 |
Close | $1.55 |
Volume / Avg. | 17.32K / 24.37K |
Day Range | 1.50 - 1.55 |
52 Wk Range | 1.21 - 5.00 |
Market Cap | $55.82M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 0.04% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Barinthus Biotherapeutics (NASDAQ:BRNS) through any online brokerage.
Other companies in Barinthus Biotherapeutics’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Estrella Immunopharma (NASDAQ:ESLA), Intensity Therapeutics (NASDAQ:INTS), Connect Biopharma Hldgs (NASDAQ:CNTB) and BioLine Rx (NASDAQ:BLRX).
There is no analysis for Barinthus Biotherapeutics.
Barinthus Biotherapeutics has a consensus price target of $5.50.
The stock price for Barinthus Biotherapeutics (NASDAQ: BRNS) is $1.43 last updated July 15, 2024 at 1:48 AM EDT.
There are no upcoming dividends for Barinthus Biotherapeutics.
Barinthus Biotherapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Barinthus Biotherapeutics.
Barinthus Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.